Trial Profile
A Retrospective study of 68Ga-PSMA-HBED-CC PET sensitivity for the diagnosis of pulmonary lesions and metastases in Prostate cancer patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Sep 2016
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Cancer metastases; Prostate cancer
- Focus Diagnostic use
- 28 Sep 2016 New trial record